National Kyushu Cancer Center

Fukuoka 811-1395

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Lymphoma, Non-Hodgkin, Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Squamous Cell Carcinoma (SCC)

Studies at this site

• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early